Aberrant nuclear factor-kappa B activity in acute myeloid Leukemia: from molecular pathogenesis to therapeutic target

The overall survival of patients with acute myeloid leukemia (AML) has not been improved significantly over the last decade. Molecularly targeted agents hold promise to change the therapeutic landscape in AML. The nuclear factor kappa B (NF-κB) controls a plethora of biological process through switc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jianbiao, Ching, Ying Qing, Chng, Wee-Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467382/
https://www.ncbi.nlm.nih.gov/pubmed/25823927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467382/
https://www.ncbi.nlm.nih.gov/pubmed/25823927

Ejemplares similares